Study on the Effectiveness and Safety of OROS Hydromorphone in Pain Management Among Patients With Cancer Pain.

Trial Profile

Study on the Effectiveness and Safety of OROS Hydromorphone in Pain Management Among Patients With Cancer Pain.

Discontinued
Phase of Trial: Phase IV

Latest Information Update: 10 Oct 2013

At a glance

  • Drugs Hydromorphone (Primary) ; Morphine; Oxycodone
  • Indications Cancer pain
  • Focus Therapeutic Use
  • Sponsors Janssen Pharmaceutica
  • Most Recent Events

    • 31 Jul 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top